Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice

BACKGROUND HCC is the most common primary liver cancer and a leading cause of cancer-related mortality. Gut microbiota is a large collection of microbes, predominately bacteria, that harbor the gastrointestinal tract. Changes in gut microbiota that deviate from the native composition, that is, "dysbiosis," is proposed as a probable diagnostic biomarker and a risk factor for HCC. However, whether gut microbiota dysbiosis is a cause or a consequence of HCC is unknown. METHODS To better understand the role of gut microbiota in HCC, mice deficient of toll-like receptor 5 (TLR5, a receptor for bacterial flagellin) as a model of spontaneous gut microbiota dysbiosis were crossed with farnesoid X receptor knockout mice (FxrKO), a genetic model for spontaneous HCC. Male FxrKO/Tlr5KO double knockout (DKO), FxrKO, Tlr5KO, and wild-type (WT) mice were aged to the 16-month HCC time point. RESULTS Compared with FxrKO mice, DKO mice had more severe hepatooncogenesis at the gross, histological, and transcript levels and this was associated with pronounced cholestatic liver injury. The bile acid dysmetabolism in FxrKO mice became more aberrant in the absence of TLR5 due in part to suppression of bile acid secretion and enhanced cholestasis. Out of the 14 enriched taxon signatures seen in the DKO gut microbiota, 50% were dominated by the Proteobacteria phylum with expansion of the gut pathobiont γ-Proteobacteria that is implicated in HCC. CONCLUSIONS Collectively, introducing gut microbiota dysbiosis by TLR5 deletion exacerbated hepatocarcinogenesis in the FxrKO mouse model.

[1]  Jun Li,et al.  The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma , 2022, Microbiology spectrum.

[2]  Hironori Yamamoto,et al.  Probiotics suppress nonalcoholic steatohepatitis and carcinogenesis progression in hepatocyte-specific PTEN knockout mice , 2022, Scientific Reports.

[3]  S. Colosimo,et al.  Bile acids as drivers and biomarkers of hepatocellular carcinoma , 2022, World journal of hepatology.

[4]  Wanlin Gao,et al.  TLR2 agonist promotes myeloid-derived suppressor cell polarization via Runx1 in hepatocellular carcinoma. , 2022, International immunopharmacology.

[5]  F. Piscaglia,et al.  Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature , 2022, Cancers.

[6]  T. Liang,et al.  Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes , 2022, Science advances.

[7]  Junhui Li,et al.  Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4 , 2022, Clinical and molecular hepatology.

[8]  M. Sarma,et al.  Newer variants of progressive familial intrahepatic cholestasis , 2021, World journal of hepatology.

[9]  Yue Cai,et al.  The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies , 2021, Liver Cancer.

[10]  C. Trautwein,et al.  Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling , 2021, Nature Metabolism.

[11]  K. Hase,et al.  Profiling of tumour-associated microbiota in human hepatocellular carcinoma , 2021, Scientific Reports.

[12]  C. Strassburg,et al.  A genetic variant in toll-like receptor 5 is linked to chemokine levels and hepatocellular carcinoma in steatohepatitis , 2021, Zeitschrift für Gastroenterologie.

[13]  P. Tsai,et al.  Hepatocellular carcinoma-derived high mobility group box 1 triggers M2 macrophage polarization via a TLR2/NOX2/autophagy axis , 2020, Scientific Reports.

[14]  Noam Shental,et al.  The human tumor microbiome is composed of tumor type–specific intracellular bacteria , 2020, Science.

[15]  M. Heikenwalder,et al.  Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota , 2020, Gut microbes.

[16]  A. Gudkov,et al.  TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects , 2020, PloS one.

[17]  P. Lampertico,et al.  Epidemiology and surveillance for hepatocellular carcinoma: New trends. , 2020, Journal of hepatology.

[18]  William A. Walters,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[19]  Shan Jiang,et al.  TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma , 2019, Cancer medicine.

[20]  Yewei Zhang,et al.  Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma , 2019, Gut Pathogens.

[21]  F. Gonzalez,et al.  Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development , 2018, Hepatology communications.

[22]  J. Lapek,et al.  Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer , 2018, Cell.

[23]  H. Saito,et al.  Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice , 2018, Oncotarget.

[24]  A. Iwama,et al.  Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity. , 2017, Cancer discovery.

[25]  E. Tsochatzis,et al.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.

[26]  J. Lupski,et al.  Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis , 2016, Nature Communications.

[27]  Gianni Panagiotou,et al.  Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice , 2016, Proceedings of the National Academy of Sciences.

[28]  S. Gollnick,et al.  Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis , 2016, Proceedings of the National Academy of Sciences.

[29]  U. Apte,et al.  Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer. , 2015, Advances in pharmacology.

[30]  R. Ley,et al.  Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. , 2014, Gastroenterology.

[31]  J. Round,et al.  Defining dysbiosis and its influence on host immunity and disease , 2014, Cellular microbiology.

[32]  P. Hylemon,et al.  Bile acids and the gut microbiome , 2014, Current opinion in gastroenterology.

[33]  Masahira Hattori,et al.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.

[34]  Jingfeng Liu,et al.  Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[35]  J. Chiang,et al.  Mechanism of tissue‐specific farnesoid X receptor in suppressing the expression of genes in bile‐acid synthesis in mice , 2012, Hepatology.

[36]  William A. Walters,et al.  Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. , 2012, Cell host & microbe.

[37]  Raul Rabadan,et al.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.

[38]  Y. Yen,et al.  Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression. , 2012, Molecular endocrinology.

[39]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[40]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[41]  R. Ley,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2010, Science.

[42]  S. Akira,et al.  Deletion of TLR5 results in spontaneous colitis in mice. , 2007, The Journal of clinical investigation.

[43]  S. Kliewer,et al.  Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine Published, JLR Papers in Press, August 24, 2007. , 2007, Journal of Lipid Research.

[44]  J. Ward,et al.  Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. , 2007, Carcinogenesis.

[45]  Yun Yen,et al.  Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. , 2007, Cancer research.

[46]  E. C. Lai,et al.  HEPATOCELLULAR CARCINOMA PRESENTING WITH OBSTRUCTIVE JAUNDICE , 2006, ANZ journal of surgery.

[47]  S. Wright,et al.  Lithocholic Acid Decreases Expression of Bile Salt Export Pump through Farnesoid X Receptor Antagonist Activity* , 2002, The Journal of Biological Chemistry.

[48]  Neil Hunter,et al.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.

[49]  C. Hagedorn,et al.  Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. , 2001, The Journal of clinical investigation.

[50]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.